Clinical Trial Update: NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing NK cells as consolidation therapy after initial treatment for acute myeloid leukemia in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia
• Myeloid Leukemia

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Acute Myeloid Leukemia, Leukemia | Phase 2 | Status: COMPLETED